Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause Squamous cell carcinoma? 18 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Squamous cell carcinoma have been filed in association with TACROLIMUS\TACROLIMUS ANHYDROUS. This represents 0.3% of all adverse event reports for TACROLIMUS\TACROLIMUS ANHYDROUS.
18
Reports of Squamous cell carcinoma with TACROLIMUS\TACROLIMUS ANHYDROUS
0.3%
of all TACROLIMUS\TACROLIMUS ANHYDROUS reports
7
Deaths
3
Hospitalizations
How Dangerous Is Squamous cell carcinoma From TACROLIMUS\TACROLIMUS ANHYDROUS?
Of the 18 reports, 7 (38.9%) resulted in death, 3 (16.7%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS\TACROLIMUS ANHYDROUS. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause?
Off label use (708)
Death (321)
Transplant rejection (278)
Diarrhoea (257)
Pyrexia (243)
Alopecia (232)
Drug ineffective (198)
Transplant dysfunction (198)
Hospitalisation (194)
Pneumonia (193)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which TACROLIMUS\TACROLIMUS ANHYDROUS Alternatives Have Lower Squamous cell carcinoma Risk?
TACROLIMUS\TACROLIMUS ANHYDROUS vs TADALAFIL
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB-CXIX